Trials / Completed
CompletedNCT06874504
Clinical Validation of the Norbert Health Device for Pulse Rate Measurement
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- Norbert Health · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The study will evaluate the measuring pulse rate (PR) using the Norbert Device (ND) as compared to a reference heart rate measured using an electrocardiogram (ECG).
Detailed description
The study design is to validate the pulse rate accuracy. The study is a non-randomized, non-blinded single arm design to evaluate the clinical accuracy of the ND's pulse rate measurement compared to a reference heart rate manually measured by observing R-peaks in a standard concurrently recorded ECG from an FDA 510(k)-cleared reference clinical ECG (RCECG). The sponsor will ensure that the study staff enrolls a range of subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Norbert Device | The Norbert Device (ND) is a contactless, noninvasive device that provides measurements of pulse rate. |
Timeline
- Start date
- 2025-03-13
- Primary completion
- 2025-04-01
- Completion
- 2025-04-11
- First posted
- 2025-03-13
- Last updated
- 2025-06-10
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06874504. Inclusion in this directory is not an endorsement.